Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of fezolinetant compared with desvenlafaxine in women with moderate-to-severe vasomotor symptoms
TCTR20260502009Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine, Prince of Songkhla University
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fezolinetant, desvenlafaxine in menopause, sponsored by Faculty of Medicine, Prince of Songkhla University. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
fezolinetantdesvenlafaxine
03
Conditions
menopause
Beyond the preview
Go deeper on TCTR20260502009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260502009.